Related Experiment Videos

Renin as a risk factor in essential hypertension: more evidence

H R Brunner, J E Sealey, J H Laragh

The American Journal of Medicine

|September 1, 1973

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Endothelin inhibition as a biologic target for treating hypertension.

American journal of hypertension·1998

Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells.

Arteriosclerosis, thrombosis, and vascular biology·1998

Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.

Journal of hypertension·1998

Effects of MDL 100,240, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase on the vasopressor response to exogenous angiotensin I and angiotensin II challenges in healthy volunteers.

Journal of cardiovascular pharmacology·1998

Blood pressure and endocrine effects of single doses of CS-866, a novel angiotensin II antagonist, in salt-restricted hypertensive patients.

Journal of hypertension·1998

Age-related changes of the mechanical properties of the carotid artery in spontaneously hypertensive rats.

Journal of hypertension·1998

See all related articles